Medical Device Autism Spectrum Disorder Therapeutics Market | Page 3

REPORT DESCRIPTION
Autism Spectrum Disorder Therapeutics Market – Dynamics
Increasing prevalence of ASD worldwide is expected to boost the Autism Spectrum Disorder Therapeutics
(ASD) therapeutics market growth. For instance, according to the data published in Our World in Data in
2017, around 62 million people worldwide were estimated to have ASD in 2016. Moreover, under 50
million of these cases were found in males. Of this 62 million with ASD, around 18 million had only
Autism and 44 million had Asperger syndrome and other spectrum disorders.
However, stringent regulations and continuous watch employed by governing authorities for product
approval and marketing of medicines can act as a potential hindrance for growth of the autism spectrum
disorder therapeutics market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA)
shut down operations of Louisiana-based Pick and Pay Inc. / Cili Minerals, a manufacturer of drug and
dietary supplements, after finding that the company was falsely marketing products as being able to treat
autism.
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2643